The U.S. FDA has declined to approve Viatris and Mapi Pharma’s once-a-month injection for treating relapsing forms of multiple sclerosis (MS), the companies said on Monday. The companies were reviewing the content of the health regulator’s complete response letter and would… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]
Published on March 11, 2024
Smaller class sizes in schools are failing to increase the resilience of children from low-income families, according to a new study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for […]
Published on March 10, 2024
Scientists have found our visual perception dips as our feet hit the ground. Further understanding this could help develop early diagnostics for neuromuscular or psychiatric illness; understand changes in mobility as we age; or help with sports science and athletic training. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]
Published on March 9, 2024